West Pharmaceutical Services, Inc.

213,88 €

1,56 €(0,74 %)

West Pharmaceutical Services, Inc.

WST

213,88 €

1,56 €(0,74 %)

West Pharmaceutical Services, Inc.

WST

NYSE

213,88 €

1,56 €(0,74 %)

Chart

Upcoming Earnings

Next report date

Apr 23, 2026

Report period

Q2 2026

EPS Estimate

1,47 €

Revenue Estimate

680,50 Mio. €

Key stats

52-Week Range213,88 €

163,53 €

281,23 €

Market capitalization

15,40 Mrd. €

Dividend yield (indicated)

0,35 %

Price to earnings Ratio (TTM)

35,64

Basic EPS (TTM)

5,96 €

Net income (TTM)

430,74 Mio. €

Revenue (TTM)

2,68 Mrd. €

Avg. volume

955,62K

Beta (1Y)

1,18

Employees

10,60K

Market capitalization

15,40 Mrd. €

Dividend yield (indicated)

0,35 %

Price to earnings Ratio (TTM)

35,64

Basic EPS (TTM)

5,96 €

Net income (TTM)

430,74 Mio. €

Revenue (TTM)

2,68 Mrd. €

Avg. volume

955,62K

Beta (1Y)

1,18

Employees

10,60K

Screener Quick Check

About West Pharmaceutical Services, Inc.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Eric Green

Website

www.westpharma.com

Headquarters

530 Herman O. West Drive, Exton, PA, 19341-0645

IPO Date

1980-03-17

Identifiers

ISINUS9553061055

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and...

Related Stocks

Quest Diagnostics Incorporated

DGX

172,01 €Mkt Cap: 19,14 Mrd. €

Healthcare

Medical - Diagnostics & Research

ISIN:US74834L1008

Labcorp Holdings Inc.

229,99 €Mkt Cap: 19,07 Mrd. €

Healthcare

Medical - Equipment & Services

ISIN:US5049221055

Dividend Overview

Dividend yield (indicated)

0,35 %

Dividend per share

0,75 €annual

Payout ratio (Earnings)

12,4 %

Payout ratio (FCF)

13,3 %

Dividend growth streak

Dividend CAGR (3Y)

-17,0 %

Dividend CAGR (5Y)

-8,6 %

Dividend CAGR (10Y)

-1,1 %

Dividend yield (indicated)

0,35 %

Dividend per share

0,75 €annual

Payout ratio (Earnings)

12,4 %

Payout ratio (FCF)

13,3 %

Dividend growth streak

Dividend CAGR (3Y)

-17,0 %

Dividend CAGR (5Y)

-8,6 %

Dividend CAGR (10Y)

-1,1 %

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate